- Home
- HSCS vs NBY Comparison
HSCS vs NBY Comparison
Compare HSCS & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- NBY
- Stock Information
- Founded
- HSCS 2007
- NBY 2000
- Country
- HSCS United States
- NBY United States
- Employees
- HSCS N/A
- NBY N/A
- Industry
- HSCS Medical Specialities
- NBY
- Sector
- HSCS Health Care
- NBY
- Exchange
- HSCS Nasdaq
- NBY Nasdaq
- Market Cap
- HSCS 3.7M
- NBY 3.5M
- IPO Year
- HSCS 2022
- NBY 2007
- Fundamental
- Price
- HSCS $3.87
- NBY $0.60
- Analyst Decision
- HSCS Strong Buy
- NBY Strong Buy
- Analyst Count
- HSCS 2
- NBY 1
- Target Price
- HSCS $13.00
- NBY $0.85
- AVG Volume (30 Days)
- HSCS 68.9K
- NBY 32.1K
- Earning Date
- HSCS 07-28-2025
- NBY 08-12-2025
- Dividend Yield
- HSCS N/A
- NBY N/A
- EPS Growth
- HSCS N/A
- NBY N/A
- EPS
- HSCS N/A
- NBY 0.57
- Revenue
- HSCS N/A
- NBY $9,781,000.00
- Revenue This Year
- HSCS N/A
- NBY $23.91
- Revenue Next Year
- HSCS N/A
- NBY $32.05
- P/E Ratio
- HSCS N/A
- NBY $1.33
- Revenue Growth
- HSCS 261.17
- NBY 20.52
- 52 Week Low
- HSCS $2.36
- NBY $0.36
- 52 Week High
- HSCS $5.77
- NBY $2.47
- Technical
- Relative Strength Index (RSI)
- HSCS 52.06
- NBY 53.58
- Support Level
- HSCS $3.66
- NBY $0.56
- Resistance Level
- HSCS $4.03
- NBY $0.64
- Average True Range (ATR)
- HSCS 0.30
- NBY 0.03
- MACD
- HSCS 0.01
- NBY -0.00
- Stochastic Oscillator
- HSCS 41.11
- NBY 44.44
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.